Blue Trust Inc’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249 Sell
10
-41
-80% -$960 ﹤0.01% 2385
2026
Q1
$715 Hold
51
﹤0.01% 2302
2025
Q4
$573 Sell
51
-7
-12% -$80 ﹤0.01% 2370
2025
Q3
$670 Buy
58
+38
+190% +$445 ﹤0.01% 2380
2025
Q2
$245 Buy
20
+10
+100% +$126 ﹤0.01% 2371
2025
Q1
$143 Hold
10
﹤0.01% 2436
2024
Q4
$159 Buy
+10
New +$198 ﹤0.01% 2390
2024
Q1
Sell
-53
Closed -$1K 2196
2023
Q4
$1K Buy
+53
New +$1.09K ﹤0.01% 2260
2023
Q1
Sell
-4
Closed 2299
2022
Q4
$0 Hold
4
﹤0.01% 2226
2022
Q3
$0 Buy
+4
New +$105 ﹤0.01% 2078

Other funds holding AVNS

Blue Trust Inc's AVNS Position: Q2 2026 in Review

Blue Trust Inc reduced its Avanos Medical (AVNS) stake by 80% in Q2 2026, selling an estimated $960 and leaving 10 shares worth $249. The position accounts for ﹤0.01% of the portfolio, ranked #2385.

Blue Trust Inc first reported a position in AVNS in Q3 2022 and has held it in 10 quarters since. The position peaked at $1K in Q4 2023. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Blue Trust Inc held 10 shares of Avanos Medical worth $249 as of Q2 2026.
  • Blue Trust Inc sold 41 Avanos Medical shares in Q2 2026, an estimated $960.
  • Avanos Medical made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2385 holding.
  • Blue Trust Inc first reported a position in Avanos Medical in Q3 2022 and has held it in 10 quarters since.
  • Blue Trust Inc's Avanos Medical position peaked at $1K in Q4 2023.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.